Key Metrics
MARKET CAP
$29.01B
P/E RATIO
35.6
BETA
1.49
More volatile
DIV YIELD
N/A
52W HIGH
$89.98
52W LOW
$54.11
VOLATILITY
36.3%
30d annualized
Price Performance
30-DAY PRICE CHART
$73.67 → $74.38+0.96%
30 days agoToday
1-YEAR PERFORMANCE
$88.37 → $74.38-15.8%
DXCM | 52-week chartLast updated: 2/27/2026
Healthcare Sector Context
Competitors Analysis
Technical Analysis
DexCom Inc. is currently trading at $74.38, which is 17.3% below its 52-week high. With a beta of 1.49, the stock shows higher sensitivity to market movements.
RSI (14)NEUTRAL
30-DAY TRENDNEUTRAL
VOLUME2.9M(Below avg)
Frequently Asked Questions
Is DXCM a good buy right now?
DexCom Inc. trades at 35.6x earnings. This is above market average, reflecting growth expectations. Current risk level is High based on 36.3% volatility.
Does DXCM pay dividends?
DexCom Inc. does not currently pay a regular dividend. The company may be reinvesting profits for growth.
How volatile is DXCM?
With 30-day annualized volatility of 36.3% and beta of 1.49,DXCM is classified as High risk. Expect larger swings than the broader market during volatile periods.
Related Assets
LLYANALYZE →
Eli Lilly and Company
NVOANALYZE →
Novo Nordisk A/S
UNHANALYZE →
UnitedHealth Group
JNJANALYZE →
Johnson & Johnson
ABBVANALYZE →
AbbVie Inc.
Track DXCM Live
Add DexCom Inc. to your Portfolio Terminal for real-time alerts and risk updates.
OPEN TERMINALLast updated: 2/27/2026, 2:03:44 PM